Indeed, MLN4924 coupled with V-9302, an ASCT2 inhibitor, significantly suppresses growth of breast cancer cells more effectively than either compound used alone, both in vitro and in vivo. The gene discussed is SLC1A5; the disease is breast carcinoma.